Trial
NCT03635112
Efficacy and Safety of TD-1473 in Crohn's Disease
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Theravance Biopharma
Collaborators
—
Condition
Crohn's Disease
Intervention
Placebo
Why stopped
The study was terminated by the sponsor on 16 November 2021 after a planned review by the Independent Data Monitoring Committee.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-13